Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα

Blood

Volumn 117, Issue 15, 2011, Pages 4032-4040

  Sato, Noriko ^a   Sabzevari, Helen ^a   Fu, Song ^a   Ju, Wei ^a   Petrus, Michael N ^a   Bamford, Richard N ^b   Waldmann, Thomas A ^a   Tagaya, Yutaka ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Transponics   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79954603487     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-307504     Document Type: Article

References (29)

1. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol. 1999;17:19-49. (Pubitemid 29241118)
2. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657-679.
3. Becknell B, Caligiuri MA. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol. 2005;86:209-239. (Pubitemid 40215694)
4. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem. 2002;277(33):29355-29358. (Pubitemid 41079217)
5. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191(5):771-780.
6. Dubois S, Patel HJ, Zhang M, Waldmann TA, Muller JR. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. J Immunol. 2008;180(4):2099- 2106.
7. Carson W, Caligiuri MA. Interleukin-15 as a potential regulator of the innate immune response. Braz J Med Biol Res. 1998;31(1):1-9. (Pubitemid 128524605)
8. Rausch A, Hessmann M, Holscher A, et al. Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms for CD8+ T cells. Eur J Immunol. 2006;36(5):1156-1167.
9. Surh CD, Boyman O, Purton JF, Sprent J. Hemostasis of memory T cells. Immunol Rev. 2006;211:154-163.
10. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci U S A. 2004;101(45):16004-16009. (Pubitemid 39507917)
11. Fehniger TA, Suzuki K, Ponnappan A, et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phonotype CD8+ T cells. J Exp Med. 2001;193(2):219-231. (Pubitemid 32524453)
12. Yokohama A, Mishra A, Mitsui T, et al. A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphcyte leukemia. LeukRes. 2010;34(2):203-209.
13. Marks-Konczalik J, Dubois S, Losi JM, et al. IL-2-induced activation-induced cell death is inhibited in IL-15-transgenic mice. Proc Natl Acad Sci USA. 2000;97(21):11445-11450.
14. Sato N, Patel HJ, Waldmann TA, Tagaya Y. IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contribute to the long survival of CD8 memory Tcells. Proc Natl Acad Sci U S A. 2007;104(2):588-593. (Pubitemid 46123069)
15. Bream JH, Hodge DL, Gonsky R, et al. Adistal region of the interferon-gamma gene is a site of epigenetic modeling and transcriptional regulation by interleukin-2. J Biol. Chem. 2004;279(39):41249-41257. (Pubitemid 39287727)
16. Levin MC, Fox RJ, Lehky T, et al. PCR-in situ hybridization detection of human T-cell lymphotropic virus type 1 (HTLV-1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1-associated neurologic disease. J Virol. 1996;70(2):924-933. (Pubitemid 26029009)
17. Terabe M, Tagaya Y, Zhu Q, et al. IL-15 expands unconventional CD8alphaalphaNK1.1 + Tcells but not Valpha14Jalpha18+ NKT cells. J Immunol. 2008;180(11):7276-7286.
18. Bergamaschi C, Rosati M, Japah R, et al. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity. J Biol Chem. 2008;283(7):4189-4199.
19. Mortier E, Woo T, Advincula R, Gozalo S, Ma A. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med. 2008;12:205 (5): 1213-1225. (Pubitemid 351679694)
20. Sandau MM, Schluns KS, Lefrancois L, Jameson SC. Transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells. J Immunol. 2004;173(11):6537-6541. (Pubitemid 39541036)
21. Gross DS. Nuclease hypersensitive sites in chromatin. Annul Rev Biochem. 1988;57:159-197.
22. Li LC, Dahiya R. Methprimer: designing primers for methylation PCRs. Bioinformatics. 2002;18(11):1427-1431. (Pubitemid 35414532)
23. Bendelac A, Kileen N, Littman DR, Schwartz RH. Asubset of CD4+ thymocytes selected by MHC class I molecules. Science. 1994;263(5154):1774-1778. (Pubitemid 24131588)
24. Lambolez F, Kronenberg M, Cheroutre H. Thymic differentiation of TCR alpha beta (+) CD8 alpha alpha (+) IELs. Immunol Rev. 2007;215:178-188. (Pubitemid 46212239)
25. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity. 2002;17(5):537-547. (Pubitemid 35351500)
26. Mangan S, Zaslaver A, Alou U. The coherent feed-forward loop serves as a sign-sensitive delay element in transcription networks. JMol Biol. 2003;334(2):197-204. (Pubitemid 37361089)
27. Lodolce JP, Burkett PR, Boone DL, Chien M, Ma A. T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. JExpMed. 2001;194(8):1187-1194.
28. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6(8):595-601. (Pubitemid 44134092)
29. Stoklasek TA, Schluns KS, Lefrancois L. Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J Immunol. 2006;177(9):6072- 6080. (Pubitemid 44628822)